產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
MRC-5 (人胚肺細(xì)胞) (STR鑒定正確)
貨號(hào)：CL-0161
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價(jià)格： ￥1600
生長(zhǎng)培養(yǎng)基：MEM（含NEAA）＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | MRC-5 (人胚肺細(xì)胞) (STR鑒定正確) |
| 別稱 | MRC5; MRC 5; MRCV; MRC-V; Medical Research Council cell strain-5 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 成纖維細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 注意事項(xiàng) | 該細(xì)胞為有限傳代細(xì)胞系，傳代次數(shù)過(guò)高會(huì)導(dǎo)致細(xì)胞生長(zhǎng)特性發(fā)生變化，建議到貨3代內(nèi)完成實(shí)驗(yàn)。 |
| 年齡（性別） | 男性；14周齡 |
| 組織來(lái)源 | 肺 |
| 細(xì)胞類型 | 有限細(xì)胞系 |
| 生物安全等級(jí) | BSL-1 |
| 保藏機(jī)構(gòu) | ATCC; CCL-171 ECACC; 97112601 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X,Y CSF1PO 11,12 D2S1338 20 D3S1358 15,17 D5S818 11,12 D7S820 10,11 D8S1179 13 D13S317 11,14 D16S539 9,11 D18S51 15,21 D19S433 14,15 D21S11 31.2 FGA 21,23 PentaD 12 PentaE 12,16 TH01 8 TPOX 8 vWA 15 D6S1043 11,19 D12S391 20,22 D2S441 10,11 -
STR鑒定圖
-
參考文獻(xiàn)
-
Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells(2022/03/04)
作者：Peilu Song, Fan Zhao, Dahong Li
期刊：Acta Pharmaceutica Sinica B
DOI：10.1016/j.apsb.2022.02.029
影響因子 ：14.500
引用產(chǎn)品：CL-0161
-
Intelligent Dual-Lock Deoxyribonucleic Acid Automatons Boosting Precise Tumor Imaging(2023/01/10)
作者：Liu Wang, Kang Wang, Xiaohui Wang
期刊：ACS Applied Materials & Interfaces
影響因子 ：9.500
-
Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression(2023/01/28)
作者：Yan Liao, Zeqin Fu, Yinfu Huang
期刊：Cell Death & Disease
DOI：10.1038/s41419-023-05597-3
影響因子 ：9.000
-
Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma(2023/01/12)
作者：Jing Zhang, Haijing Song, Yanan Dong
期刊：International Journal of Nanomedicine
影響因子 ：8.000
-
A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis(2023/11/14)
作者：Chuanqing Jing, Rong Fu, Xue Liu
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1268141
影響因子 ：7.300
引用產(chǎn)品：CL-0161
-
Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy(2024/01/06)
作者：Haobing Wang, Yidan Lai, Dan Li
期刊：JOURNAL OF MEDICINAL CHEMISTRY
DOI：10.1021/acs.jmedchem.3c01889
影響因子 ：7.300
引用產(chǎn)品：CL-0161
-
Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis(2023/04/14)
作者：Tianming Zhao, Xu Wu, Xuelei Zhao
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1159856
影響因子 ：7.300
-
CCL17 drives fibroblast activation in the progression of pulmonary fibrosis by enhancing the TGF-β/Smad signaling(2023/03/02)
作者：Qianrong Wang, Suosi Liu, Jiali Min
期刊：BIOCHEMICAL PHARMACOLOGY
影響因子 ：5.800
引用產(chǎn)品：CL-0161
-
Circular RNA circESPL1 knockdown alleviates lipopolysaccharide (LPS)-induced lung cell injury via sponging miR-326 to regulate MAPK14(2022/08/26)
作者：Yamei Liang, Yingying Miao, Jingjing Xiang
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2022.109146
影響因子 ：5.600
-
Circ_0044411 silencing protects infantile pneumonia from lipopolysaccharide-induced cell injury by sponging miR-141-3p to inhibit CCL16 expression(2022/12/19)
作者：Yanhui Yu, Ran Wang, Hui Zhang
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2022.109425
影響因子 ：5.600
引用產(chǎn)品：CL-0161
-
1β-Hydroxyalantolactone from Inulae Flos alleviated the progression of pulmonary fibrosis via inhibiting JNK/FOXO1/NF-κB pathway(2021/11/07)
作者：Bing Yu, Xiaoqing Jin, Wenying Yu
期刊：International Immunopharmacology
DOI：10.1016/j.intimp.2021.108339
影響因子 ：5.600
引用產(chǎn)品：CL-0161
-
Co-treatment of nicotinamide mononucleotide and neoagarooligosaccharide mitigates aging-induced cognitive impairment by promoting mitochondrial dynamics(2023/11/29)
作者：Tao Li, Yanxiao Li, Qiaojuan Yan
期刊：Journal of Functional Foods
影響因子 ：5.600
引用產(chǎn)品：CL-0161
-
Anti-carbamylated protein antibodies drive AEC II toward a profibrotic phenotype by interacting with carbamylated TLR5(2024/02/16)
作者：Wei Xu, Minghua Huang, Rongrong Dong
期刊：RHEUMATOLOGY
DOI：10.1093/rheumatology/keae111
影響因子 ：5.500
引用產(chǎn)品：CL-0161
-
YuPingFeng (YPF) upregulates caveolin-1 (CAV1) to alleviate pulmonary fibrosis through the TGF-β1/Smad2 pathway(2023/10/28)
作者：Xiao Chen, Min Wei, Guodong Li
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
引用產(chǎn)品：CL-0161
-
Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients(2023/06/10)
作者：Lu Yan, Minyue Jiang, Xinsheng Fan
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
引用產(chǎn)品：CL-0161
-
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3(2022/11/12)
作者：Wu Xu, Zhang Hui, Jiang Gang, Peng Minlian, Li Cheng, Lu Jiaxin, Jiang Shiyin, Yang Xiaoping, Jiang Yongliang
期刊：Clinical And Experimental Immunology
影響因子 ：4.600
-
High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT(2024/05/16)
作者：Shijing You, Xiahui Han, Yuance Xu
期刊：Cancer Medicine
影響因子 ：4.000
引用產(chǎn)品：CL-0161
-
Cevanine-type alkaloids from the bulbs of Fritillaria unibracteata var. wabuensis and their antifibrotic activities in vitro(2024/02/10)
作者：Lu Fu, Wenyue Tian, Mengyu Bao
期刊：PHYTOCHEMISTRY
DOI：10.1016/j.phytochem.2024.114018
影響因子 ：3.800
引用產(chǎn)品：CL-0161
-
Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs(2023/10/04)
作者：Zhang Zhenzhen, Guan Qingzhou, Tian Yange
期刊：BMC Pulmonary Medicine
DOI：10.1186/s12890-023-02678-z
影響因子 ：3.100
引用產(chǎn)品：CL-0161
-
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma(2023/02/24)
作者：Rui Chen, Zhiping Wang, Tianzhu Lu
期刊：Thoracic Cancer
影響因子 ：2.900
引用產(chǎn)品：CL-0016 CL-0161 CL-0165 CL-0166 CL-0298 CL-0668 CM-0161
-
Circ_0026579 knockdown ameliorates lipopolysaccharide-induced human lung fibroblast cell injury by regulating CXCR1 via miR-370-3p(2023/10/02)
作者：Yuanhong Zhuang, Yuyun Yang, Lihong Peng
期刊：CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
影響因子 ：2.900
引用產(chǎn)品：CL-0161
-
Krüppel-like factor 15 counteracts endoplasmic reticulum stress and suppresses lung fibroblast proliferation and extracellular matrix accumulation(2023/07/26)
作者：Xiang Han, Weiqin Wu, Shuming Wang
期刊：TISSUE & CELL
DOI：10.1016/j.tice.2023.102183
影響因子 ：2.600
引用產(chǎn)品：CL-0161
-
Circ_0038467 regulates lipopolysaccharide-mediated cell proliferation, apoptosis, and inflammatory response by miR-195-5p/TLR4 axis through NF-κB pathway in MRC-5 cells(2021/03/22)
作者：Yu Zheng, Yuanyuan Wang, Xiuli Zhu
期刊：Bioscience Biotechnology and Biochemistry
影響因子 ：1.600
引用產(chǎn)品：CL-0161
-
Hsa_circ_0079530/AQP4 Axis Is Related to Non-Small Cell Lung Cancer Development and Radiosensitivity.(2022/10/01)
作者：Xianghui Yang, Min Li, Yang Zhao
期刊：Annals of Thoracic and Cardiovascular Surgery
影響因子 ：1.300
-
SMURF1-Interference Effects Autophagy and Pulmonary Fibrosis through SMAD7 and the TGF-β1/SMAD Pathway(2024/05/02)
作者：Lin L., Xue D., Chen L.-M.
期刊：MOLECULAR BIOLOGY
影響因子 ：1.200
引用產(chǎn)品：CL-0161
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
